| Analysis | Metabolite Name | Measured Value | Units | level of dysplasia | malignant transformation |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 1088 | Peak area | HGD & PDA | yes |
| Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 1884 | Peak area | N/A | No |
| Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 3039 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 7835 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 11894 | Peak area | HGD & PDA | Yes |
| Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 15313 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | Peak area | HGD | No | |
| Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | Peak area | LGD | No | |
| Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | Peak area | N/A | No | |
| Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 2957 | Peak area | HGD & PDA | yes |
| Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 4442 | Peak area | LGD | No |
| Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 5003 | Peak area | N/A | No |
| Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 9458 | Peak area | HGD & PDA | Yes |
| Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 18198 | Peak area | LGD | No |
| Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | Peak area | HGD | No | |
| Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | Peak area | LGD | No | |
| Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | Peak area | N/A | No |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|